Profile | GDS4284 / 220796_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 10932 | 97 |
GSM687648 | Patient 402 control | 11686.3 | 98 |
GSM687653 | Patient 403 control | 9586.88 | 97 |
GSM687658 | Patient 404 control | 18145.9 | 99 |
GSM687663 | Patient 411 control | 20497.1 | 99 |
GSM687668 | Patient 422 control | 12790.3 | 98 |
GSM687673 | Patient 424 control | 16119.7 | 98 |
GSM687678 | Patient 425 control | 18523.4 | 99 |
GSM687683 | Patient 427 control | 15143 | 98 |
GSM687688 | Patient 428 control | 13846.5 | 98 |
GSM687695 | Patient 441 control | 5082.49 | 94 |
GSM687699 | Patient 443 control | 10540.5 | 97 |
GSM687704 | Patient 444 control | 23406.6 | 99 |
GSM687707 | Patient 448 control | 25887.4 | 99 |
GSM687712 | Patient 449 control | 13074.9 | 98 |
GSM687719 | Patient 450 control | 11186.7 | 98 |
GSM687724 | Patient 451 control | 17206.7 | 98 |
GSM687728 | Patient 452 control | 12127.6 | 98 |
GSM687646 | Patient 401 treated 24h | 12517.1 | 98 |
GSM687649 | Patient 402 treated 24h | 10682.9 | 97 |
GSM687665 | Patient 411 treated 24h | 11150.3 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 17453.4 | 99 |
GSM687667 | Patient 411 treated 4 weeks | 11962.3 | 98 |
GSM687670 | Patient 422 treated 24h | 16702.4 | 98 |
GSM687671 | Patient 422 treated 4 weeks | 14975.3 | 98 |
GSM687654 | Patient 403 treated 24h | 11773.9 | 97 |
GSM687675 | Patient 424 treated 24h | 11777.8 | 98 |
GSM687685 | Patient 427 treated 24h | 12147 | 98 |
GSM687656 | Patient 403 treated 4 weeks | 10636 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 26529.7 | 99 |
GSM687687 | Patient 427 treated 4 weeks | 12807.2 | 98 |
GSM687692 | Patient 428 treated 4h | 11647.6 | 98 |
GSM687716 | Patient 449 treated 4h | 17242.2 | 98 |
GSM687722 | Patient 450 treated 4h | 10537.5 | 97 |
GSM687680 | Patient 425 treated 24h | 8663.83 | 97 |
GSM687690 | Patient 428 treated 24h | 9056.68 | 97 |
GSM687700 | Patient 443 treated 24h | 11881.2 | 98 |
GSM687705 | Patient 444 treated 24h | 21562.3 | 99 |
GSM687714 | Patient 449 treated 24h | 13013.5 | 98 |
GSM687721 | Patient 450 treated 24h | 7404.16 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 16041 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 14689.5 | 98 |
GSM687702 | Patient 443 treated 4 weeks | 15195.5 | 98 |
GSM687718 | Patient 449 treated 4 weeks | 36914 | 99 |
GSM687723 | Patient 450 treated 4 weeks | 9971.91 | 97 |
GSM687661 | Patient 404 treated 4h | 15647.9 | 98 |
GSM687710 | Patient 448 treated 4h | 17745.1 | 98 |
GSM687726 | Patient 451 treated 4h | 18729.1 | 99 |
GSM687730 | Patient 452 treated 4h | 49301.2 | 99 |
GSM687660 | Patient 404 treated 24h | 7054.01 | 95 |
GSM687697 | Patient 441 treated 24h | 9306.15 | 97 |
GSM687709 | Patient 448 treated 24h | 19159 | 99 |
GSM687725 | Patient 451 treated 24h | 18690.7 | 99 |
GSM687729 | Patient 452 treated 24h | 7225.61 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 23449.6 | 99 |
GSM687731 | Patient 452 treated 4 weeks | 13643.3 | 98 |